DE69333208D1 - Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen - Google Patents

Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen

Info

Publication number
DE69333208D1
DE69333208D1 DE69333208T DE69333208T DE69333208D1 DE 69333208 D1 DE69333208 D1 DE 69333208D1 DE 69333208 T DE69333208 T DE 69333208T DE 69333208 T DE69333208 T DE 69333208T DE 69333208 D1 DE69333208 D1 DE 69333208D1
Authority
DE
Germany
Prior art keywords
substituted
taxans
isobutenyl
pharmaceutical compositions
side chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333208T
Other languages
English (en)
Other versions
DE69333208T2 (de
Inventor
Robert A Holton
Ki-Byung Chai
Hossain Nadizadeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University
Original Assignee
Florida State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/975,705 external-priority patent/US5284864A/en
Priority claimed from US08/005,229 external-priority patent/US5338872A/en
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Priority claimed from US08/026,978 external-priority patent/US5990325A/en
Priority claimed from US08/034,247 external-priority patent/US5430160A/en
Application filed by Florida State University filed Critical Florida State University
Publication of DE69333208D1 publication Critical patent/DE69333208D1/de
Application granted granted Critical
Publication of DE69333208T2 publication Critical patent/DE69333208T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/62Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69333208T 1992-11-13 1993-11-01 Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen Expired - Fee Related DE69333208T2 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US07/975,705 US5284864A (en) 1991-09-23 1992-11-13 Butenyl substituted taxanes and pharmaceutical compositions containing them
US975705 1992-11-13
US5229 1993-01-15
US08/005,229 US5338872A (en) 1993-01-15 1993-01-15 Process for the preparation of 10-desacetoxybaccatin III and 10-desacetoxytaxol and derivatives thereof
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US10798 1993-01-29
US26978 1993-03-05
US08/026,978 US5990325A (en) 1993-03-05 1993-03-05 Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
US08/034,247 US5430160A (en) 1991-09-23 1993-03-22 Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US34247 1993-03-22
US9471993A 1993-07-20 1993-07-20
US94719 1993-07-20
PCT/US1993/010813 WO1994010996A1 (en) 1992-11-13 1993-11-01 Butenyl-substituted taxanes and composition

Publications (2)

Publication Number Publication Date
DE69333208D1 true DE69333208D1 (de) 2003-10-23
DE69333208T2 DE69333208T2 (de) 2004-04-08

Family

ID=27555508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333208T Expired - Fee Related DE69333208T2 (de) 1992-11-13 1993-11-01 Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen

Country Status (11)

Country Link
EP (1) EP0668762B1 (de)
JP (2) JPH08503218A (de)
CN (2) CN1065240C (de)
AT (1) ATE249826T1 (de)
CA (1) CA2147984C (de)
DE (1) DE69333208T2 (de)
DK (1) DK0668762T3 (de)
ES (1) ES2206465T3 (de)
IL (1) IL107554A (de)
PT (1) PT668762E (de)
WO (1) WO1994010996A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
US5405972A (en) * 1993-07-20 1995-04-11 Florida State University Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
JPH10508022A (ja) * 1994-10-28 1998-08-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
EP1391459A1 (de) * 1999-08-11 2004-02-25 Bristol-Myers Squibb Company Verfahren zur Herstellung eines Paclitaxel C-4 Methyl-Carbonat Analogen und Zwischenprodukte
EP1664033B1 (de) 2003-09-25 2007-11-07 Tapestry Pharmaceuticals, Inc. 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung
SI1664033T1 (sl) * 2003-09-25 2008-04-30 Tapestry Pharmaceuticals Inc Analogi 9,10-alfa,alfa-oh-taksana in postopki za proizvodnjo le-teh
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) * 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam

Also Published As

Publication number Publication date
CA2147984A1 (en) 1994-05-26
CN1270958A (zh) 2000-10-25
EP0668762A4 (de) 1995-12-20
ATE249826T1 (de) 2003-10-15
CN1205184C (zh) 2005-06-08
AU706985B2 (en) 1999-07-01
IL107554A0 (en) 1994-02-27
JPH08503218A (ja) 1996-04-09
AU2621097A (en) 1997-09-18
CN1065240C (zh) 2001-05-02
DE69333208T2 (de) 2004-04-08
JP2006257108A (ja) 2006-09-28
IL107554A (en) 2005-03-20
EP0668762B1 (de) 2003-09-17
WO1994010996A1 (en) 1994-05-26
EP0668762A1 (de) 1995-08-30
PT668762E (pt) 2004-02-27
AU5667094A (en) 1994-06-08
ES2206465T3 (es) 2004-05-16
CN1092416A (zh) 1994-09-21
AU677267B2 (en) 1997-04-17
CA2147984C (en) 2006-03-14
DK0668762T3 (da) 2004-01-05

Similar Documents

Publication Publication Date Title
DE69333208D1 (de) Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen
NO930677D0 (no) Farmasoeytiske forbindelser
FR2700167B1 (fr) Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
DE59207053D1 (de) Kettenumlenkung
DE69401335T2 (de) Gleiskettenspannvorrichtung
DE69014666T2 (de) Abgabe von cytotoxischen Mitteln.
DE4294862T1 (de) Pharmazeutische Komposition
DE69305597D1 (de) Treibriemen
ATE319698T1 (de) Taxane mit alkyl substituierte seiten-kette und diese enthaltende pharmazeutische zusammenstellungen
ITTO920114A1 (it) Derivati bis-tetrazolici ad attivita' antiallergica e citoprotettiva
DE69306449T2 (de) Puls-Laser-Quelle
FR2659714B3 (fr) Chaine travaillant en poussee.
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
IL109049A0 (en) Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
DE69003056T2 (de) S-Alkylthiopropionsäuren und deren Derivate.
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
ITMI911344A1 (it) Associazione farmaceutica ad attivita' antineoplastica
DE69405544T2 (de) 4'-0-sulfonylanthracyclinderivate
ITMI921863A1 (it) Derivati 1, 4-benzotiazinici ad attivita' calcio antagonista
LT2417B (lt) Mo budas vaiku astrios leukozes nepalankios eigos isaiskini
KR920013331U (ko) 아이들러(idler)의 2단 구동장치
ZA938217B (en) Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
ITLT910005V0 (it) Atomizzatore "tricomma"
BR1100960A (pt) Composto, e, composição farmacêutica
BR1100596A (pt) Composto e formulações farmacêuticas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee